Caveney came to the newly created role in September 2017 after serving as chief medical officer  of Blue Cross and Blue Shield of North Carolina. He oversees the company’s medical and scientific strategy. LabCorp played a key role in expanding COVID-19 testing capabilities nationally. In late April the company became the first to win Food and Drug Administration approval of a diagnostic test that allowed for at-home collection of a sample.